Furthermore, PARP inhibition seems to augment cytotoxic T cell tumor infiltration through activation of the cGAS/STING innate immune pathway, leading to increased levels of chemokines, such as CXCL10 and CCL5, that induce the activation and function of cytotoxic CD8+ T cells [103,104]. This evidence concerns the gene PARP1 and neoplasm.